Research & Development News
Tattooing is a more effective way of administering DNA vaccines than direct injection
Pharmathen's new Research and Development Centre in Pallini, Athens
Labs are Vital(TM) Program Targets Science-Minded Students Through Facebook Social Media Network
In an effort to attract young people to the clinical laboratory profession, Labs Are Vital(TM), an initiative sponsored by Abbott, has tapped into Facebook, a popular social networking Web site, to reach out to more than four million students with an interest in life sciences. Thomson Healthcare Online Treatment Tools Mark Milestone
More than one million people have used Thomson Healthcare (NYSE: TOC; TSX: TOC) Profiler treatment option tools to help make treatment decisions for cancer, heart disease and lung disease. "When you consider more than 20 million people are diagnosed with cancer, heart disease or lung disease each year, this is not the kind of milestone one celebrates," said Alicia Moffat, Thomson Healthcare's vice president of Web operations. Discovery of gene locus associated with cardiovascular disease raises hope of new treatments
FDA Notifies Public of Adverse Reactions Linked to Botox Use
The U.S. Food and Drug Administration notified the public that Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been linked in some cases to adverse reactions, including respiratory failure and death, following treatment of a variety of conditions using a wide range of doses. More Pharma News ...
Business & Industry
- Pfizer reports record full-year 2022 results
- AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
- CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
- Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
- Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries
Research & Development
- Transforming the way cancer vaccines are designed and made
- Antidepressants used for chronic pain on the rise, but are they effective?
- Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
- Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
- Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
- Power of cancer drugs may see boost by targeting newly ID'd pathway
- A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA grants Accelerated Approval for Alzheimer's disease treatment
- FDA approves new HIV drug for adults with limited treatment options
- FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
- FDA approves first gene therapy to treat adults with Hemophilia B
- FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease